NERV FY 2017 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$51M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$11,094

Operating Income

-$41M

Net Income

-$32M

EPS (Diluted)

$-6.65

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$184M

Total Liabilities

$52M

Stockholders' Equity

$132M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$11,094	-$16,530	+32.9%
Operating Income	-$41M	-$30M	-36.4%
Net Income	-$32M	-$31M	-1.5%